{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T10:25:28Z","timestamp":1787307928260,"version":"build-2736575974"},"reference-count":62,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004881","name":"Instituto Mexicano del Seguro Social","doi-asserted-by":"publisher","award":["R-2025-785-007"],"award-info":[{"award-number":["R-2025-785-007"]}],"id":[{"id":"10.13039\/501100004881","id-type":"DOI","asserted-by":"publisher"}]},{"award":["R-2025-785-007"],"award-info":[{"award-number":["R-2025-785-007"]}],"id":[{"id":"https:\/\/ror.org\/03xddgg98","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background\/Objectives: Nutritional status and adipose tissue-derived mediators have been implicated in the development and clinical characteristics of epithelial ovarian carcinoma; however, studies integrating circulating adipokines, adipokine receptor expression, and nutritional status remain limited. This study aimed to evaluate circulating adipokine concentrations, adipokine receptor expression, nutritional status parameters, and their associations with clinically relevant features and disease stage in women with epithelial ovarian carcinoma. Methods: A total of 151 women were included, comprising 43 patients with epithelial ovarian carcinoma, 89 with benign ovarian tumors, and 19 healthy controls. The nutritional status parameters included body composition, dietary intake, and serum glucose concentration. Circulating adipokines were quantified by ELISA, whereas adipokine receptor expression was evaluated by automated immunohistochemistry in patients with available tumor tissue. Associations with clinicopathological variables were assessed using correlation analyses and multivariable regression models. Results: Compared with women with benign ovarian tumors, women with epithelial ovarian carcinoma had significantly lower circulating leptin concentrations, whereas their circulating resistin concentrations were significantly higher than in healthy controls. In multivariable analysis, lower leptin and higher resistin concentrations were associated with clinical disease classification, while lower leptin was also associated with advanced-stage disease. Visceral fat was associated with clinical disease classification. In addition, AdipoR1 expression was significantly more frequent in malignant than in benign ovarian tumors. Conclusions: Circulating leptin and resistin, visceral fat, and AdipoR1 expression were associated with clinically relevant characteristics across the study groups. Together, these findings provide a more comprehensive characterization of the metabolic and inflammatory alterations associated with epithelial ovarian carcinoma and may contribute to the identification of potential clinically relevant markers.<\/jats:p>","DOI":"10.3390\/cancers18162712","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T09:31:59Z","timestamp":1787304719000},"page":"2712","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Circulating Adipokines, Tissue Receptor Expression, and Body Composition: Clinical Relevance and Disease Stage in Epithelial Ovarian Carcinoma"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-3427-0854","authenticated-orcid":false,"given":"Lizeth Montserrat","family":"Aguilar-Vazquez","sequence":"first","affiliation":[{"name":"Programa de Doctorado en Ciencias en Biolog\u00eda Molecular en Medicina, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela Nohemi","family":"Espinoza-de-Le\u00f3n","sequence":"additional","affiliation":[{"name":"Divisi\u00f3n de Inmunolog\u00eda, Centro de Investigaci\u00f3n Biom\u00e9dica de Occidente (CIBO),  Instituto Mexicano del Seguro Social (IMSS), Guadalajara 44340, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7054-5467","authenticated-orcid":false,"given":"Ricardo Misael","family":"Alem\u00e1n-Montes","sequence":"additional","affiliation":[{"name":"Divisi\u00f3n de Inmunolog\u00eda, Centro de Investigaci\u00f3n Biom\u00e9dica de Occidente (CIBO),  Instituto Mexicano del Seguro Social (IMSS), Guadalajara 44340, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego Alberto","family":"Morales-Soto","sequence":"additional","affiliation":[{"name":"Departamento de Anatom\u00eda Patol\u00f3gica, Divisi\u00f3n de Auxiliares del Diagn\u00f3stico y Tratamiento, Centro M\u00e9dico Nacional de Occidente, Instituto Mexicano del Seguro Social (IMSS), Guadalajara 44340, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Ramon","family":"Lopez-Lopez","sequence":"additional","affiliation":[{"name":"Departamento de Anatom\u00eda Patol\u00f3gica, Divisi\u00f3n de Auxiliares del Diagn\u00f3stico y Tratamiento, Centro M\u00e9dico Nacional de Occidente, Instituto Mexicano del Seguro Social (IMSS), Guadalajara 44340, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjam\u00edn","family":"Gonz\u00e1lez-Am\u00e9zquita","sequence":"additional","affiliation":[{"name":"Unidad M\u00e9dica de Alta Especialidad, Hospital de Ginecolog\u00eda y Obstetricia, Centro M\u00e9dico Nacional de Occidente, Instituto Mexicano del Seguro Social (IMSS), Guadalajara 44340, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Villegas-Pacheco","sequence":"additional","affiliation":[{"name":"Unidad M\u00e9dica de Alta Especialidad, Hospital de Ginecolog\u00eda y Obstetricia, Centro M\u00e9dico Nacional de Occidente, Instituto Mexicano del Seguro Social (IMSS), Guadalajara 44340, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo Antonio","family":"Alcaraz-Wong","sequence":"additional","affiliation":[{"name":"Departamento de Anatom\u00eda Patol\u00f3gica, Divisi\u00f3n de Auxiliares del Diagn\u00f3stico y Tratamiento, Centro M\u00e9dico Nacional de Occidente, Instituto Mexicano del Seguro Social (IMSS), Guadalajara 44340, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5922-7216","authenticated-orcid":false,"given":"Iris Monserrat","family":"Llamas-Covarrubias","sequence":"additional","affiliation":[{"name":"Instituto de Nutrigen\u00e9tica y Nutrigen\u00f3mica Traslacional, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Mart\u00ednez-L\u00f3pez","sequence":"additional","affiliation":[{"name":"Instituto de Nutrigen\u00e9tica y Nutrigen\u00f3mica Traslacional, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9288-4824","authenticated-orcid":false,"given":"Adriana","family":"Aguilar-Lemarroy","sequence":"additional","affiliation":[{"name":"Divisi\u00f3n de Inmunolog\u00eda, Centro de Investigaci\u00f3n Biom\u00e9dica de Occidente (CIBO),  Instituto Mexicano del Seguro Social (IMSS), Guadalajara 44340, Mexico"},{"name":"Unidad de Investigaci\u00f3n Epidemiol\u00f3gica y en Servicios de Salud, Instituto Mexicano del Seguro Social (IMSS), Guadalajara 44340, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6209-5031","authenticated-orcid":false,"given":"Luis Felipe","family":"Jave-Su\u00e1rez","sequence":"additional","affiliation":[{"name":"Divisi\u00f3n de Inmunolog\u00eda, Centro de Investigaci\u00f3n Biom\u00e9dica de Occidente (CIBO),  Instituto Mexicano del Seguro Social (IMSS), Guadalajara 44340, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,21]]},"reference":[{"key":"ref_1","first-page":"e70090","article-title":"Global cancer statistics 2024: GLOBOCAN estimates of incidence and mortality worldwide for 34 cancers in 186 countries","volume":"76","author":"Sung","year":"2026","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"932371","DOI":"10.1155\/2010\/932371","article-title":"Ovarian cancer pathogenesis: A model in evolution","volume":"2010","author":"Karst","year":"2010","journal-title":"J. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/ijgo.70282","article-title":"Cancer of the ovary, fallopian tube, and peritoneum: 2025 update","volume":"171","author":"Renz","year":"2025","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"ref_4","first-page":"100629","article-title":"Epithelial ovarian cancer: Review article","volume":"33","author":"Sambasivan","year":"2022","journal-title":"Cancer Treat. Res. Commun."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"101718","DOI":"10.1016\/j.gore.2025.101718","article-title":"The role of diet, obesity and body composition in epithelial ovarian cancer development and progression: Mechanisms and therapeutic implications","volume":"58","author":"Suratkal","year":"2025","journal-title":"Gynecol. Oncol. Rep."},{"key":"ref_6","first-page":"93","article-title":"Epidemiology and risk factors for ovarian cancer","volume":"22","author":"Ali","year":"2023","journal-title":"Prz. Menopauzalny"},{"key":"ref_7","first-page":"e1618","article-title":"Anthropometric factors and the risk of ovarian cancer: A systematic review and meta-analysis","volume":"5","author":"Ellwanger","year":"2022","journal-title":"Cancer Rep."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Aprile, G., Basile, D., Giaretta, R., Schiavo, G., La Verde, N., Corradi, E., Monge, T., Agustoni, F., and Stragliotto, S. (2021). The Clinical Value of Nutritional Care before and during Active Cancer Treatment. Nutrients, 13.","DOI":"10.3390\/nu13041196"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1757-2215-7-41","article-title":"Obesity and epithelial ovarian cancer survival: A systematic review and meta-analysis","volume":"7","author":"Bae","year":"2014","journal-title":"J. Ovarian Res."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Cai, B., Li, K., and Li, G. (2022). Impact of Obesity on Major Surgical Outcomes in Ovarian Cancer: A Meta-Analysis. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.841306"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e13699","DOI":"10.1002\/jcsm.13699","article-title":"Prevalence and Prognostic Significance of Sarcopenia in Gynecologic Oncology: A Systematic Review and Meta-Analysis","volume":"16","author":"Jiang","year":"2025","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1515\/hmbci-2014-0037","article-title":"Adipose tissue, obesity and adipokines: Role in cancer promotion","volume":"21","author":"Booth","year":"2015","journal-title":"Horm. Mol. Biol. Clin. Investig."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Garcia-Miranda, A., Solano-Alcala, K.A., Montes-Alvarado, J.B., Rosas-Cruz, A., Reyes-Leyva, J., Navarro-Tito, N., Maycotte, P., and Castaneda-Saucedo, E. (2021). Autophagy Mediates Leptin-Induced Migration and ERK Activation in Breast Cancer Cells. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.644851"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nri2921","article-title":"Adipokines in inflammation and metabolic disease","volume":"11","author":"Ouchi","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Rahmati Nezhad, P., Riihil\u00e4, P., Knuutila, J.S., Viiklepp, K., Peltonen, S., Kallajoki, M., Meri, S., Nissinen, L., and K\u00e4h\u00e4ri, V.M. (2022). Complement Factor D Is a Novel Biomarker and Putative Therapeutic Target in Cutaneous Squamous Cell Carcinoma. Cancers, 14.","DOI":"10.3390\/cancers14020305"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Tsankof, A., and Tziomalos, K. (2022). Adiponectin: A player in the pathogenesis of hormone-dependent cancers. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.1018515"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Kolakowska, K., Kisluk, J., and Niklinski, J. (2025). A Novel Insight into the Role of Obesity-Related Adipokines in Ovarian Cancer-State-of-the-Art Review and Future Perspectives. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26051857"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Wroblewski, M., Szewczyk-Golec, K., Holynska-Iwan, I., Wroblewska, J., and Wozniak, A. (2021). Characteristics of Selected Adipokines in Ascites and Blood of Ovarian Cancer Patients. Cancers, 13.","DOI":"10.3390\/cancers13184702"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Molina-Pineda, A., Jauregui-Salazar, F.O., Zamudio-Martinez, A.G., Vizcarra-Ramos, S., Garcia-Gomez, J., Gonzalez-Amezquita, B., Aguilar-Vazquez, L.M., Villegas-Pacheco, R., Hernandez-Gutierrez, R., and Jave-Suarez, L.F. (2025). Utility of a Multimodal Biomarker Panel and Serum Proapoptotic Activity to Refine Diagnosis of Ovarian Adnexal Masses. Diseases, 13.","DOI":"10.3390\/diseases13100342"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13048-019-0503-7","article-title":"Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review","volume":"12","author":"Dochez","year":"2019","journal-title":"J. Ovarian Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1200\/JCO.1999.17.5.1474","article-title":"Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer","volume":"17","author":"Harvey","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"ref_22","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"216057","DOI":"10.1016\/j.canlet.2023.216057","article-title":"Molecular characteristics and clinical behaviour of epithelial ovarian cancers","volume":"555","author":"Hollis","year":"2023","journal-title":"Cancer Lett."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.20892\/j.issn.2095-3941.2016.0084","article-title":"Epidemiology of ovarian cancer: A review","volume":"14","author":"Reid","year":"2017","journal-title":"Cancer Biol. Med."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Smolarz, B., Biernacka, K., Lukasiewicz, H., Samulak, D., Piekarska, E., Romanowicz, H., and Makowska, M. (2025). Ovarian Cancer-Epidemiology, Classification, Pathogenesis, Treatment, and Estrogen Receptors\u2019 Molecular Backgrounds. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26104611"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/sj.bjc.6606092","article-title":"HE4 and CA125 as a diagnostic test in ovarian cancer: Prospective validation of the Risk of Ovarian Malignancy Algorithm","volume":"104","author":"Cadron","year":"2011","journal-title":"Br. J. Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.currproblcancer.2018.06.001","article-title":"Comparison of CA125, HE4, and ROMA index for ovarian cancer diagnosis","volume":"43","author":"Zhang","year":"2019","journal-title":"Curr. Probl. Cancer"},{"key":"ref_28","first-page":"709","article-title":"Exploring awareness, perceptions, and practices relating to nutritional status and low muscle mass in patients with ovarian cancer","volume":"33","author":"Kiss","year":"2025","journal-title":"Support. Care Cancer"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13048-023-01098-1","article-title":"High visceral fat-to-muscle ratio is an independent factor that predicts worse overall survival in patients with primary epithelial ovarian, fallopian tube, and peritoneal cancer","volume":"16","author":"Ham","year":"2023","journal-title":"J. Ovarian Res."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Cuello, M.A., Gomez, F., Wichmann, I., Suarez, F., Kato, S., Orlandini, E., Branes, J., and Ibanez, C. (2023). Body Composition and Metabolic Dysfunction Really Matter for the Achievement of Better Outcomes in High-Grade Serous Ovarian Cancer. Cancers, 15.","DOI":"10.3390\/cancers15041156"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ygyno.2013.03.003","article-title":"Nutritional status, CT body composition measures and survival in ovarian cancer","volume":"129","author":"Torres","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1177\/0300060517706578","article-title":"Cardiovascular risk of adipokines: A review","volume":"46","author":"Dutheil","year":"2018","journal-title":"J. Int. Med. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1515\/hmbci-2014-0047","article-title":"Visceral adiposopathy: A vascular perspective","volume":"21","author":"Farb","year":"2015","journal-title":"Horm. Mol. Biol. Clin. Investig."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Kolb, H. (2022). Obese visceral fat tissue inflammation: From protective to detrimental?. BMC Med., 20.","DOI":"10.1186\/s12916-022-02672-y"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Behrouzi, R., Ryan, N.A.J., Barr, C.E., Derbyshire, A.E., Wan, Y.L., Maskell, Z., Stocking, K., Pemberton, P.W., Bolton, J., and McVey, R.J. (2020). Baseline Serum HE4 But Not Tissue HE4 Expression Predicts Response to the Levonorgestrel-Releasing Intrauterine System in Atypical Hyperplasia and Early Stage Endometrial Cancer. Cancers, 12.","DOI":"10.3390\/cancers12020276"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.21037\/tcr-2025-758","article-title":"Ovarian cancer and malnutrition: A literature review","volume":"14","author":"Shao","year":"2025","journal-title":"Transl. Cancer Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"279","DOI":"10.5468\/ogs.2016.59.4.279","article-title":"Association of plasma adiponectin and leptin levels with the development and progression of ovarian cancer","volume":"59","author":"Jin","year":"2016","journal-title":"Obstet. Gynecol. Sci."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Hasenburg, A., Eichkorn, D., Vosshagen, F., Obermayr, E., Geroldinger, A., Zeillinger, R., and Bossart, M. (2021). Biomarker-based early detection of epithelial ovarian cancer based on a five-protein signature in patient\u2019s plasma\u2014A prospective trial. BMC Cancer, 21.","DOI":"10.1186\/s12885-021-08682-y"},{"key":"ref_39","first-page":"318","article-title":"Evaluation of leptin serum concentrations during surgery and first-line chemotherapy in primary epithelial ovarian cancer patients","volume":"18","author":"Grabowski","year":"2014","journal-title":"Contemp. Oncol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"57","DOI":"10.5603\/EP.a2018.0081","article-title":"The role of adiponectin and leptin in the treatment of ovarian cancer patients","volume":"70","author":"Slomian","year":"2019","journal-title":"Endokrynol. Pol."},{"key":"ref_41","first-page":"5","article-title":"Gynaecological cancers and leptin: A focus on the endometrium and ovary","volume":"10","author":"Ray","year":"2018","journal-title":"Facts Views Vis. Obgyn"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"93530","DOI":"10.18632\/oncotarget.19873","article-title":"Leptin receptor signaling via Janus kinase 2\/Signal transducer and activator of transcription 3 impacts on ovarian cancer cell phenotypes","volume":"8","author":"Kumar","year":"2017","journal-title":"Oncotarget"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1111\/j.1582-4934.2008.00408.x","article-title":"Interleukin-6 and leptin as markers of energy metabolic changes in advanced ovarian cancer patients","volume":"13","author":"Madeddu","year":"2009","journal-title":"J. Cell. Mol. Med."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Lane, D., Matte, I., Garde-Granger, P., Laplante, C., Carignan, A., Rancourt, C., and Piche, A. (2015). Inflammation-regulating factors in ascites as predictive biomarkers of drug resistance and progression-free survival in serous epithelial ovarian cancers. BMC Cancer, 15.","DOI":"10.1186\/s12885-015-1511-7"},{"key":"ref_45","first-page":"160","article-title":"Serum CA125 and ascites leptin level ratio predicts baseline clinical resistance to first-line platinum-based treatment and poor prognosis in patients with high grade serous ovarian cancer","volume":"9","author":"Matte","year":"2019","journal-title":"Am. J. Cancer Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"6796","DOI":"10.7150\/jca.62496","article-title":"Resistin Expression in Epithelial Ovarian Cancer promotes the Proliferation and Migration of Ovarian Cancer Cells to Worsen Prognosis","volume":"12","author":"Pang","year":"2021","journal-title":"J. Cancer"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"9751","DOI":"10.3390\/ijms14059751","article-title":"Resistin promotes the expression of vascular endothelial growth factor in ovary carcinoma cells","volume":"14","author":"Pang","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"12522","DOI":"10.1038\/s41598-018-30978-6","article-title":"Novel oncogenic and chemoresistance-inducing functions of resistin in ovarian cancer cells require miRNAs-mediated induction of epithelial-to-mesenchymal transition","volume":"8","author":"Qiu","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1179554917690144","DOI":"10.1177\/1179554917690144","article-title":"Effects of Serum Leptin and Resistin Levels on Cancer Cachexia in Patients With Advanced-Stage Non-Small Cell Lung Cancer","volume":"11","author":"Demiray","year":"2017","journal-title":"Clin. Med. Insights Oncol."},{"key":"ref_50","first-page":"416","article-title":"Serum levels of adipokines resistin and leptin in patients with colon cancer","volume":"3","author":"Salageanu","year":"2010","journal-title":"J. Med. Life"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s12291-020-00891-9","article-title":"Hyperinsulinemia and Hypoadiponectinemia are Associated with Increased Risk for Occurrence of Ovarian Cancer in Non-diabetic Women of North Indian Population","volume":"36","author":"Gupta","year":"2021","journal-title":"Indian J. Clin. Biochem."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"71","DOI":"10.5937\/jomb0-26452","article-title":"Effects of adiponectin, plasma D-dimer, inflammation and tumor markers on clinical characteristics and prognosis of patients with ovarian cancer","volume":"41","author":"Li","year":"2022","journal-title":"J. Med. Biochem."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"4987","DOI":"10.7314\/APJCP.2015.16.12.4987","article-title":"Associations of Serum Isoflavone, Adiponectin and Insulin Levels with Risk for Epithelial Ovarian Cancer: Results of a Case-control Study","volume":"16","author":"Otokozawa","year":"2015","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.2337\/diacare.26.12.3315","article-title":"Plasma adiponectin and endogenous glucose production in humans","volume":"26","author":"Stefan","year":"2003","journal-title":"Diabetes Care"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"103893","DOI":"10.1016\/j.jprot.2020.103893","article-title":"Identification and validation of differential plasma proteins levels in epithelial ovarian cancer","volume":"226","author":"Periyasamy","year":"2020","journal-title":"J. Proteom."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.eatbeh.2014.03.001","article-title":"The prediction role of indexes of circulating adipokines for common anthropometric and nutritional characteristics of obesity in the obese Central European population","volume":"15","author":"Novak","year":"2014","journal-title":"Eat. Behav."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.12659\/MSM.899990","article-title":"Expression of Adiponectin Receptor-1 and Prognosis of Epithelial Ovarian Cancer Patients","volume":"23","author":"Li","year":"2017","journal-title":"Med. Sci. Monit."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s12672-010-0017-7","article-title":"Adiponectin receptor expression in human malignant tissues","volume":"1","author":"Chou","year":"2010","journal-title":"Horm. Cancer"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s12672-018-0331-z","article-title":"Adiponectin Reverses the Proliferative Effects of Estradiol and IGF-1 in Human Epithelial Ovarian Cancer Cells by Downregulating the Expression of Their Receptors","volume":"9","author":"Hoffmann","year":"2018","journal-title":"Horm. Cancer"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/IGC.0000000000000369","article-title":"Expression of adiponectin and its receptors is altered in epithelial ovarian tumors and ascites-derived ovarian cancer cell lines","volume":"25","author":"Tiwari","year":"2015","journal-title":"Int. J. Gynecol. Cancer Off. J. Int. Gynecol. Cancer Soc."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1476-4598-8-74","article-title":"Overexpression of leptin receptor predicts an unfavorable outcome in Middle Eastern ovarian cancer","volume":"8","author":"Uddin","year":"2009","journal-title":"Mol. Cancer"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3892\/br.2013.125","article-title":"Expression of leptin receptor in endometrial biopsies of endometrial and ovarian cancer patients","volume":"1","year":"2013","journal-title":"Biomed. Rep."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/16\/2712\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T09:42:18Z","timestamp":1787305338000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/16\/2712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":62,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["cancers18162712"],"URL":"https:\/\/doi.org\/10.3390\/cancers18162712","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]}}}